NOCIL growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
−6.4%−3.6%−10.6%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−26.7%−29.5%−22.8%
−45.2%−41.1%−27.8%
−45.9%−22.7%−10.8%
−46.0%−22.7%−10.8%
+2.6%+2.1%+8.5%
+0.6%+3.7%+9.4%
+886.2%−87.3%−28.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NOCIL₹145.35

NOCIL Limited

· Chemicals
₹ CrorePeersHSCLROSSARINAVINFLUORDDEVPLSTIKTATACHEMCHEMPLASTSAARTIINDJGCHEMMcap ₹2,428 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—-10.6-3.6-6.4—
EBITDA Growth—-22.8-29.5-26.7—
EBIT Growth—-27.8-41.1-45.2—
Net Income Growth—-10.8-22.7-45.9—
EPS Growth—-10.8-22.7-46.0—
Total Assets Growth—+8.5+2.1+2.6—
Total Equity Growth—+9.4+3.7+0.6—
Cash from Operations Growth—-28.7-87.3+886.2—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.